centraljersey.comHEALTH MATTERS: Immunotherapy to fight cancercentraljersey.comThis decrease reflects the progress made in prevention and early diagnosis as well as advances in new treatment approaches, including immunotherapy, a rapidly advancing form… Continue reading
Science Daily |
First ‘haploid’ human stem cells could change the face of medical research
Science Daily Until now, scientists have only succeeded in creating haploid embryonic stem cells — which contain a single set of chromosomes — in non-human mammals such as mice, rats and monkeys. However, scientists have long sought to isolate and replicate these … The Stem Cell RevolutionSeeking Alpha Stem–cell researchers solve mystery of relapse in acute myeloid leukemiaMedical Xpress Researchers discover protein that makes stem cells into perfect …News-Medical.net Technology Networks –Business Record all 32 news articles » |
|
Extension of US Patent and Trademark Office’s Cancer Immunotherapy Pilot Program
The National Law Review On June 19, 2017, the U.S. Patent and Trademark Office (USPTO) announced that it would be extending the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immunotherapy to be examined in an expedited fashion … |
Proactive Investors UK |
Widecells Groups claims landmark as stem cell insurance goes on sale in the UK
Proactive Investors UK “We are leveraging Biovault’s register of over 25,000 samples to generate sales of our innovatively complete stem cell insurance product and are delighted that all new customers of the UK’s leading cord blood storage facility will become customers of … |
Medical Xpress |
Stem–cell researchers solve mystery of relapse in acute myeloid leukemia
Medical Xpress “For the first time, we have married together knowledge of stem cell biology and genetics – areas that historically have often been operating as separate camps – to identify mutations stem cells carry and how they are related to one another in AML … First ‘haploid’ human stem cells could change the face of medical researchEurekAlert (press release) |
|
Funding of research center developing nanomaterials for cancer immunotherapy extended
EurekAlert (press release) The German Research Foundation (DFG) has agreed to fund the Mainz-based Collaborative Research Center (CRC) 1066 “Nanodimensional Polymer Therapeutics for Tumor Therapy” involved in the development of nanomaterials for cancer immunotherapy … |
Targeted Oncology |
Bb2121 Induces 100% Response Rate in Multiple Myeloma
Targeted Oncology According to findings from a small phase I study, all patients with multiple myeloma showed a response following treatment with an active dose of bb2121, an investigational anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell … |